Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Deutsche Bank $2.5 billion notes offerings
We advised on two fixed-to-floating-rate eligible liabilities notes offerings
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
ACG Metals de-SPAC transaction to acquire the Gediktepe mine in Turkey
The shares are listed on the London Stock Exchange
Oesterreichische Kontrollbank $1 billion notes offering
The 3.75% notes are due 2029
Gates Industrial $386 million secondary offering
The offering involved 23 million ordinary shares
NatWest Group $1.75 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Clariane €92 million reserved capital increase and €237 million rights offering
We advised Clariane on its refinancing transactions